Geneva, June 22 -- International Clinical Trials Registry received information related to the study (ChiCTR2600126584) titled 'Multimodal artificial intelligence-assisted prostate cancer detection and risk stratification in men with low PSA (<4 ng/ml): a prospective multicenter study' on June 11.

Study Type: Diagnostic test

Study Design: Diagnostic test for accuracy

Primary Sponsor: West China Hospital of Sichuan University

Condition: Prostate cancer

Intervention: Gold Standard:Histopathological examination of specimens obtained from prostate biopsy or radical prostatectomy

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-06-22

Target Sample Size: Target condition:592;Difficult condition:0

Coun...